par Delabaye, Isabelle;De Keyser, Filip;Badot, Valérie ; [et al.]
Référence Arthritis research & therapy, 12, 3, page (R121)
Publication Publié, 2010
Article révisé par les pairs
Résumé : The objective was to describe the prevalence, types, and predictors of adverse events (AEs) in rheumatoid arthritis (RA) patients treated with infliximab and methotrexate in a daily clinical setting.